Dr. Mulay Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 60.47%
- Profit Growth 47.95%
- Ebitda 47.95%
- Net Worth 69.84%
- Total Assets 73.59%
About Dr. Mulay Superspeciality Hospital
Dr. Mulay Superspeciality Hospital Private Limited (DMSHPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 November 2014 and has a history of Ten years and three months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhirudra Muley and Pallavi Mulay serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999PN2014PTC153011
- Company No.
153011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2014
- Date of AGM
15 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Dr. Mulay Superspeciality Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhirudra Muley  | Director | 05-Nov-2014 | Current |
| Pallavi Mulay | Director | 05-Nov-2014 | Current |
Financial Performance of Dr. Mulay Superspeciality Hospital.
Dr. Mulay Superspeciality Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.47% increase. The company also saw a substantial improvement in profitability, with a 47.95% increase in profit. The company's net worth Soared by an impressive increase of 69.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Mulay Superspeciality Hospital?
In 2020, Dr. Mulay Superspeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Mulay Superspeciality Hospital?
Unlock and access historical data on people associated with Dr. Mulay Superspeciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Mulay Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Mulay Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.